Abstract: A method for fabricating a dye-sensitized solar cell is provided. The dye-sensitized solar cell includes a photo electrode including (a) mixing a TiO2 powder, a Zn-containing compound and an alkaline aqueous solution to form a mixture and performing a thermal process on the mixture to form a Zn-doped TiO2 powder; (b) mixing a binder solution with the Zn-doped TiO2 powder to form a paste; (c) coating the paste on a first electrode, and the paste is sintered to form a Zn-doped TiO2 porous layer, wherein the Zn-doped TiO2 porous layer and the first electrode construct a photo electrode; (d) disposing a second electrode opposite to the photo electrode after a dye is absorbed by the Zn-doped TiO2 porous layer; and (e) disposing an electrolyte between the photo electrode and the second electrode.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making thesuch proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.

Abstract: The invention provides soluble fusion protein complexes having at least two soluble fusion proteins. The first fusion protein is a biologically active polypeptide covalently linked to an interleukin-15 (IL-15) polypeptide or a functional fragment thereof. The second fusion protein is a second biologically active polypeptide covalently linked to a soluble interleukin-15 receptor alpha (IL-15R?) polypeptide or a functional fragment thereof. In the complexes of the invention, one or both of the first and second fusion proteins further includes an immunoglobulin Fc domain or a functional fragment thereof; and the first fusion protein binds to the soluble IL-15R? domain of the second fusion protein to form a soluble fusion protein complex. The invention further provides methods for making and using the complexes of the invention.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: The present invention discloses a method capable of increasing performance of a memory, where a memory system applied to the method includes a memory and a controller, and a reserved space of the memory is used for storing a logic address/physical block mapping table. The method includes the controller reserving a plurality of physical blocks of the memory as a writing buffer pool; and the controller executing width writing operation or depth writing operation on a plurality of data and the writing buffer pool according to the logic address/physical block mapping table when the plurality of data are written to the memory. The logic address/physical block mapping table includes corresponding relationships between the plurality of physical blocks and a plurality of logic addresses.

Abstract: A defect inspection method for a wafer is provided. The wafer comprises a component pattern. The method comprises the following steps: providing a defect inspection apparatus for inspecting the defects on the wafer to obtain a defect distribution map; providing a photo mask, wherein the photo mask comprises a exposure pattern corresponding to the component pattern; and comparing the defect distribution map with the exposure pattern and dividing the defects in the defect distribution map into a first killer defect group and a first non-killer defect group according to their corresponding locations in the exposure pattern. In addition, a wafer defect inspection system applying the same method is also provided.

Abstract: A movable light-guiding device includes a light-guiding unit and at least one sucker unit. The light-guiding unit includes at least one light-guiding structure. The sucker unit is installed on the light-guiding unit. Accordingly, a user can easily make the light-guiding device adhere to an object or remove it from an object by using the sucker unit. The movable light-guiding device can be repeatedly installed and uninstalled and thereby it can improve the performance and user's convenience.

Abstract: A multi-party communication control system and charge process of a DC charging system is provided. According battery pack information transmitted by a battery control system, a multi-party communication control device determines a charge current or a charge voltage and a voltage-controlled charge mode required by a battery pack. The multi-party communication control device then translates the charge voltage or the charge current to a CHAdeMO language that is next transmitted to a CHAdeMO charger.

Abstract: The invention provides soluble fusion protein complexes having at least two soluble fusion proteins. The first fusion protein is a biologically active polypeptide covalently linked to an interleukin-15 (IL-15) polypeptide or a functional fragment thereof. The second fusion protein is a second biologically active polypeptide covalently linked to a soluble interleukin-15 receptor alpha (IL-15R?) polypeptide or a functional fragment thereof. In the complexes of the invention, one or both of the first and second fusion proteins further includes an immunoglobulin Fc domain or a functional fragment thereof; and the first fusion protein binds to the soluble IL-15R? domain of the second fusion protein to form a soluble fusion protein complex. The invention further provides methods for making and using the complexes of the invention.

Abstract: A semiconductor process includes the following steps. A substrate is provided. An ozone saturated deionized water process is performed to form an oxide layer on the substrate. A dielectric layer is formed on the oxide layer. A post dielectric annealing (PDA) process is performed on the dielectric layer and the oxide layer.

Abstract: The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the such proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.

Abstract: A defect inspection method for a wafer is provided. The wafer comprises a component pattern. The method comprises the following steps: providing a defect inspection apparatus for inspecting the defects on the wafer to obtain a defect distribution map; providing a photo mask, wherein the photo mask comprises a exposure pattern corresponding to the component pattern; and comparing the defect distribution map with the exposure pattern and dividing the defects in the defect distribution map into a first killer defect group and a first non-killer defect group according to their corresponding locations in the exposure pattern. In addition, a wafer defect inspection system applying the same method is also provided.

Abstract: A driving apparatus includes a voltage transforming unit and a detector. The driving apparatus is used for supplying a drive voltage to a load. The voltage transforming unit is used for transforming a direct current (DC) voltage to the drive voltage. The detector is connected to the load for detecting a forward voltage across the load to generate a detecting voltage; wherein the detector compares the detecting voltage with a first reference voltage. If the detecting voltage is smaller than the first reference voltage, the detector generates a first feedback signal; the voltage transforming unit increases the drive voltage according to the first feedback signal, the detecting voltage is defined by subtraction of the forward voltage from the drive voltage.

Abstract: A method for fabricating a dye-sensitized solar cell is provided. The dye-sensitized solar cell includes a photo electrode including (a) mixing a TiO2 powder, a Zn-containing compound and an alkaline aqueous solution to form a mixture and performing a thermal process on the mixture to form a Zn-doped TiO2 powder; (b) mixing a binder solution with the Zn-doped TiO2 powder to form a paste; (c) coating the paste on a first electrode, and the paste is sintered to form a Zn-doped TiO2 porous layer, wherein the Zn-doped TiO2 porous layer and the first electrode construct a photo electrode; (d) disposing a second electrode opposite to the photo electrode after a dye is absorbed by the Zn-doped TiO2 porous layer; and (e) disposing an electrolyte between the photo electrode and the second electrode.

Abstract: The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the such proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.

Abstract: A driving device includes a dimmer, a rectifying-filtering unit, a rectifying-dividing unit, a control unit, and a voltage transforming unit. The dimmer is used for receiving an alternating current (AC) voltage from a power supply, and generating a primary voltage for controlling the brightness of a luminous element. The rectifying-filtering unit is used for rectifying and filtering the primary voltage to generate a secondary voltage. The rectifying-dividing unit is used for rectifying and dividing the primary voltage to generate a detecting voltage. The control unit is used for receiving the secondary voltage, and generating a pulse voltage whose duty cycle is variable with the detecting voltage. The voltage transforming unit is used for transforming the secondary voltage to a driving voltage for driving the luminous element to emit light according to the pulse voltage. A related electronic apparatus is also provided.

Abstract: The invention provides soluble fusion protein complexes having at least two soluble fusion proteins. The first fusion protein is a biologically active polypeptide covalently linked to an interleukin-15 (IL-15) polypeptide or a functional fragment thereof. The second fusion protein is a second biologically active polypeptide covalently linked to a soluble interleukin-15 receptor alpha (IL-15R?) polypeptide or a functional fragment thereof. In the complexes of the invention, one or both of the first and second fusion proteins further includes an immunoglobulin Fc domain or a functional fragment thereof; and the first fusion protein binds to the soluble IL-15R? domain of the second fusion protein to form a soluble fusion protein complex. The invention further provides methods for making and using the complexes of the invention.

Abstract: The present invention relates to a novel monascuspurpurone compound of formula (I): or a pharmaceutically acceptable derivative thereof as described in the specification, the process for preparation of the same, and the composition comprising the same. The uses of a monascuspurpurone compound for promoting adipocyte differentiation, for increasing the activity of PPAR? and/or C/EBP?, for lowering blood glucose, for preventing and/or treating a disease or disorder related to insulin resistance, and for preventing and/or treating metabolic syndrome or its complications are also provided.

Abstract: The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the such proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.